|Articles|September 1, 2003
Kasabach-Merritt Phenomenon
Author(s)Barbara J. Rutledge, Ph.D.
San Francisco - It is important to go back to the literature to study the rare phenomenon known as Kasabach-Merritt phenomenon and review the published reports in light of what we currently know about vascular tumors, according to Beth A. Drolet, M.D. "Most of these lesions do involve the skin, so we as dermatologists can play a big part in diagnosis," said Dr. Drolet, associate professor of dermatology and pediatrics, Medical College of Wisconsin.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
Dermatology Conferences and Meetings Calendar: December 2025
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5














